BioWorld MedTech

Aug. 3, 2015

View Archived Issues

Inside the Beltway: BPC says 'pragmatic' studies plus RCTs needed for premarket applications

Read More

Heartware Lifted by rival buyout: Heartware sees a 5% increase in revenue; pumped by St. Jude/Thoratec merger

Read More

Financings: Nanosphere adds amendment to $30 million term loan

Read More

Hit Bits: Calgary gains MFDS certification in Korea for ResolutionMD

Read More

MDD's Winners and Losers

Read More

MDD's Company Stock Report

Read More

MDD's Neurology Extra

Read More

Company prospects inflated by approval: FDA approval of dual balloon system could Reshape weight loss options

The market for weight loss devices has seen a flurry of recent activity, most recently with the FDA approval of an intragastric dual balloon system from Reshape Medical (San Clemente, Calif.). Read More

Shares' Value Slimming down: GI Dynamics sees stock plunge; plans to re-evaluate after ENDO trial ends

Read More